156 related articles for article (PubMed ID: 20551403)
61. Primary non-small cell lung cancer in a transplanted lung treated with stereotactic body radiation therapy. A case study.
Oskan F; Ganswindt U; Belka C; Manapov F
Strahlenther Onkol; 2014 Apr; 190(4):411-5. PubMed ID: 24638242
[TBL] [Abstract][Full Text] [Related]
62. Simultaneous stereotactic body radiation therapy of a primary non-small cell lung cancer and synchronous carcinoma in situ in a medically inoperable patient: case report.
Oskan F; Kornhuber C; Krause G; Vordermark D
Radiat Oncol; 2013 Sep; 8():213. PubMed ID: 24028532
[TBL] [Abstract][Full Text] [Related]
63. SABR in NSCLC--the beginning of the end or the end of the beginning?
Brada M; Pope A; Baumann M
Radiother Oncol; 2015 Feb; 114(2):135-7. PubMed ID: 25665955
[No Abstract] [Full Text] [Related]
64. Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens.
Siva S; Ball D
Oncologist; 2016 Apr; 21(4):393-8. PubMed ID: 26984447
[TBL] [Abstract][Full Text] [Related]
65. Stereotactic Body Radiation Therapy versus Thermal Ablation for Early Stage Non-Small Cell Lung Cancer.
Vyfhuis MAL; Mohindra P; Simone CB
Radiology; 2019 Feb; 290(2):574-575. PubMed ID: 30599098
[No Abstract] [Full Text] [Related]
66. Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoise.
Senan S
Cancer; 2013 Aug; 119(15):2668-70. PubMed ID: 23605591
[No Abstract] [Full Text] [Related]
67. Stereotactic Body Radiation Therapy: Focusing on the Short Game.
Cao C; Huang J; Rimner A; Wang D; Chung C; Jones DR
J Clin Oncol; 2018 Aug; 36(23):2455-2456. PubMed ID: 29863976
[No Abstract] [Full Text] [Related]
68. Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
Flores RM
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):403-404. PubMed ID: 28918206
[No Abstract] [Full Text] [Related]
69. Commentary: Surgery versus stereotactic body radiation therapy for patients with renal dysfunction and non-small cell lung cancer: The answer is still not clear.
Chang SH
J Thorac Cardiovasc Surg; 2022 Jul; 164(1):240-241. PubMed ID: 34865839
[No Abstract] [Full Text] [Related]
70. Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?
Guckenberger M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):765-8. PubMed ID: 26530744
[No Abstract] [Full Text] [Related]
71. Stereotactic body radiotherapy in non-operable lung cancer patients.
Vadalà RE; Santacaterina A; Sindoni A; Platania A; Arcudi A; Ferini G; Mazzei MM; Marletta D; Rifatto C; Risoleti EV; Severo C; Pontoriero A; Iatì G; Pergolizzi S
Clin Transl Oncol; 2016 Nov; 18(11):1158-1159. PubMed ID: 27686231
[No Abstract] [Full Text] [Related]
72. The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues.
Sio TT; Mohindra P; Yu NY; Ashman JB; Daniels TB; Merrell KW; Schild SE
J Clin Oncol; 2019 Oct; 37(29):2697-2699. PubMed ID: 31465261
[No Abstract] [Full Text] [Related]
73. Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.
Videtic GM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):927-930. PubMed ID: 27869093
[No Abstract] [Full Text] [Related]
74. Surgery versus stereotactic body radiation therapy for operable stage I non-small cell lung cancer: Can we achieve equipoise?
Onaitis MW; Salama J
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):1-2. PubMed ID: 27343902
[No Abstract] [Full Text] [Related]
75. Stereotactic body radiotherapy for central lung tumours.
Dahele M; Tekatli H; Senan S
Br J Radiol; 2015 Sep; 88(1053):20150410. PubMed ID: 26151617
[No Abstract] [Full Text] [Related]
76. Long-Term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligo-recurrence.
Niibe Y; Jingu K; Onishi H
J Thorac Oncol; 2017 Nov; 12(11):e191. PubMed ID: 29074214
[No Abstract] [Full Text] [Related]
77. A hypothesis: indirect cell death in the radiosurgery era.
Sperduto PW; Song CW; Kirkpatrick JP; Glatstein E
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):11-3. PubMed ID: 25835617
[No Abstract] [Full Text] [Related]
78. Is There Still a Role for Stereotactic Body Radiation Therapy in Early-Stage Lung Cancer?
Deng HY; Tang X
Ann Thorac Surg; 2021 Mar; 111(3):1092-1093. PubMed ID: 32717234
[No Abstract] [Full Text] [Related]
79. Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy?
D'Angelillo RM; Ramella S
J Thorac Oncol; 2018 Oct; 13(10):1441-1442. PubMed ID: 30244851
[No Abstract] [Full Text] [Related]
80. Treatment for pathologic stage I lung cancer--are models reliable?
Puri V; Crabtree TD; Meyers BF
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):522; author reply 523. PubMed ID: 22244284
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
